• Explore /
  • Poster
  • / Biology and performance of pre- and post-pembrolizumab (Pembro) vesical imaging–reporting and data system (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): Full data analysis from a clinical trials pipeline.

Biology and performance of pre- and post-pembrolizumab (Pembro) vesical imaging–reporting and data system (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): Full data analysis from a clinical trials pipeline.

Abstract Poster

Authors

Andrea Necchi

Andrea Necchi

Vita-Salute San Raffaele University, Milan, Italy

Andrea Necchi , Giuseppe Basile , Ewan Gibb , Daniele Raggi , Giuseppina Calareso , Laura Marandino , Tiago Costa de Padua , Damiano Alfio Patanè , Emanuele Crupi , Chiara Mercinelli , Andrea Del Prete , Patrizia Giannatempo , Marco Moschini , Jeffrey S. Ross , Alberto Briganti , Francesco Montorsi , Antonella Messina , Francesco De Cobelli , Giorgio Brembilla

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Urothelial Cancer - Local-Regional Disease

Clinical Trial Registration Number

NCT02736266

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4591)

DOI

10.1200/JCO.2023.41.16_suppl.4591

Abstract #

4591

Poster Bd #

83

Abstract Disclosures

Similar Posters

First Author: Giorgio Brembilla

First Author: Chiara Mercinelli

First Author: Andrea Necchi

First Author: Andrea Necchi